Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort study

Hepatology International 2026

View at publisher
Authors: Jheng-Yan Wu, Yu-Min Lin, Wan‐Hsuan Hsu, Ting-Hui Liu, Ya‐Wen Tsai, Po‐Yu Huang, Min-Hsiang Chuang, Tsung Yu, Chih-Cheng Lai
DOI: 10.1007/s12072-025-11021-z
Cited by: 2
References: 31

Fields of Study & Subjects

Diabetes Treatment and Management Gastroesophageal reflux and treatments Gastrointestinal motility and disorders

Publication details

Journal / source
Hepatology International
Publisher
Springer Science and Business Media LLC
Volume
20
Issue
2
Pages
292–302
Publication date
14 January 2026
Language
EN